1. At a Glance
Aether Industries just posted a decently cooked Q1 FY26 — sales grew, OPM crossed 32%, and net profit came in at ₹40 Cr. But wait — while the earnings sizzled, promoters mysteriously cut stake from 81.77% to 74.99%. Are they confident? Or just liquidating in style?
2. Introduction with Hook
Imagine a chemical company with margins slicker than your hair gel and a P/E ratio more inflated than your mutual fund’s brochure. Now add 3 business lines, a management obsessed with CRAMS, and sprinkle in promoter stake sales.
Welcome to Aether Industries — India’s homegrown specialty chemical marvel with Bollywood-style drama and Silicon Valley pricing.
Key FY26 Q1 stats:
- Revenue: ₹214 Cr (up 33% YoY)
- PAT: ₹40 Cr (flat YoY, but better than last quarter)
- OPM: 32% (finally recovering after last year’s freefall)
3. Business Model (WTF Do They Even Do?)
Aether’s business model is like a thali plate — you get a bit of everything:
- Large Scale Manufacturing (59%)
- Advanced intermediates sold to pharma, agrochem, and coatings industries.
- Think: high volumes, medium margins, global clients.
- Contract Manufacturing (26%)
- Manufacturing for large MNCs on a long-term basis.
- Think: “you bring the formula, we make the magic.”
- CRAMS (14%)
- Low-volume, high-value, niche research-based products.
- Think: nerdy chemical R&D in a lab with good lighting.
Basically, they’re the guy at the chemical party who does everyone’s homework — and then bills them
